This present disclosure relates to compounds with ferroptosis inducing activity, a method of treating a subject with cancer with the compounds, and combination treatments with a second therapeutic agent.
-
Paragraph 1284
(2019/09/06)
UREA DERIVATIVE
Disclosed is a novel compound having an NPY Y5 receptor antagonistic activity. A compound represented by the formula: its pharmaceutically acceptable salt or solvate thereof, wherein X is hydrogen or the like, Y is a group of the formula: Z is -NR7/
-
Page/Page column 16
(2009/06/27)
More Articles about upstream products of 859525-16-9